Biopharmaceutical Manufacturing Capabilities

The Agency manufactures a number of its own biopharmaceutical products including the UK’s Anthrax vaccine and Erwinase™ / Erwinaze™ which received a Biological Licence Application from the US FDA in November 2011 .

Building on this experience we are able to offer a series of bespoke developmental production services. We are also able to manufacture Biological products to GMP standards for pre-clinical, early stage clinical trial (Phase I-II) and complete manufacture for niche biological products on behalf of clients.

Bespoke Biopharmaceutical Manufacturing Services

Taking an original concept from the bench through to the production of GMP biopharmaceutical material for clinical trials is challenging. The world class expertise of the Health Protection Agency's centre at Porton Down in process development, scale-up and GMP manufacture can assist biotechnology companies to develop new vaccines, therapeutic proteins and enzyme products for today's market. We are able to offer a bespoke service designed to meet client needs and add value to client programmes. Our experience enables us to successfully manage novel products requiring a specialised service, including high containment. The Agency has its own portfolio of licensed biopharmaceutical products, which give us a clear understanding of the need to bring client products to market in a cost effective and efficient manner.

To find out more visit our contacts page